Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The designation 'Unknown/various putative gastrointestinal and circulatory targets' is a non-specific placeholder used in pharmacological databases, such as ChEMBL, to categorize therapeutic agents whose exact molecular targets remain uncharacterized or involve multiple, poorly defined pathways (ChEMBL, 2024). This classification is frequently applied to older medications, complex natural products, or physically acting agents like adsorbents and mucosal protectants that do not bind to a specific receptor or enzyme (PubChem, 2024). In the gastrointestinal tract, these agents may act through luminal adsorption or by providing a mechanical coating to the intestinal mucosa to treat conditions like diarrhea or dyspepsia (NCBI, 2023). In the circulatory system, the term may encompass substances that influence vascular integrity or hemodynamics through broad physiological effects rather than high-affinity protein interactions (StatPearls, 2023). Because this entry represents a collection of undefined interactions rather than a single biological molecule, it is considered an incorrect or non-canonical target for modern drug discovery (Nature Reviews Drug Discovery, 2021). It serves primarily as a legacy category for substances with polypharmacological profiles that resist standard target assignment.
The mechanisms of action for agents associated with this classification are generally non-specific and include physical adsorption of toxins, the formation of protective mucosal barriers, osmotic effects, or complex polypharmacological modulation of vascular tone that has not been mapped to a single molecular entity (PubChem, 2024; ChEMBL, 2024).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal and circulatory non-specific targets.